Stay updated on Durvalumab & Olaparib in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    M.D. Anderson Cancer Center was added to the collaborators list and The University of Texas MD Anderson Cancer Center was removed, the government funding notice was deleted, and the page now shows Revision: v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-11T02:49:34.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH Clinical Center operations was added, with a link to opm.gov for status updates. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-04T00:40:28.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Glossary display added; page-status labels updated to include Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Some previous labels such as Results First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4 were removed.
    Difference
    0.1%
    Check dated 2026-01-28T00:31:00.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No substantive content changes to the study details or page functionality were observed.
    Difference
    0.0%
    Check dated 2026-01-14T01:24:11.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Results have been posted for NCT04269200, with enrollment updated to 805 and 202 locations (including Erlangen, Germany). The page now lists a broad set of outcome measures (PFS, OS, PFS2, ORR, DoR, TFST, TSST, TDT, PK, ADA, and HRQoL) along with their assessment schedules.
    Difference
    1%
    Check dated 2025-12-30T13:25:22.000Z thumbnail image
  9. Check
    74 days ago
    Change Detected
    Summary
    Locations for many US states and Canadian provinces were added and removed, and a Revision: v3.3.3 appears, signaling an update to the listing of study sites.
    Difference
    1%
    Check dated 2025-12-23T09:25:16.000Z thumbnail image

Stay in the know with updates to Durvalumab & Olaparib in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.